Singapore Institute of Advanced Medicine Holdings Ltd.
Singapore Institute of Advanced Medicine Holdings Ltd. (9G2.SI) Stock Competitors & Peer Comparison
See (9G2.SI) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 9G2.SI | SGD 0.04 | +2.50% | 42.9M | -2.05 | -SGD 0.02 | N/A |
| Q0F.SI | SGD 2.87 | +1.06% | 25.4B | 35.88 | SGD 0.08 | +1.15% |
| BSL.SI | SGD 1.01 | +1.00% | 1.9B | 25.25 | SGD 0.04 | +2.48% |
| A50.SI | SGD 0.06 | -1.79% | 1.5B | N/A | N/A | N/A |
| QC7.SI | SGD 0.53 | +0.00% | 501.3M | 53.00 | SGD 0.01 | +1.55% |
| OTX.SI | SGD 0.23 | +0.00% | 30.1M | 7.50 | SGD 0.03 | +7.47% |
| Z4D.SI | SGD 0.03 | +0.00% | 5.3M | -3.10 | -SGD 0.01 | N/A |
Stock Comparison
9G2.SI vs Q0F.SI Comparison April 2026
9G2.SI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9G2.SI stands at 42.9M. In comparison, Q0F.SI has a market cap of 25.4B. Regarding current trading prices, 9G2.SI is priced at SGD 0.04, while Q0F.SI trades at SGD 2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9G2.SI currently has a P/E ratio of -2.05, whereas Q0F.SI's P/E ratio is 35.88. In terms of profitability, 9G2.SI's ROE is -0.48%, compared to Q0F.SI's ROE of +0.07%. Regarding short-term risk, 9G2.SI is more volatile compared to Q0F.SI. This indicates potentially higher risk in terms of short-term price fluctuations for 9G2.SI.Check Q0F.SI's competition here